Skip to content
Discovery history

From melanoma research to puberty genetics

I expected a reproductive signal to have a reproductive origin. The opening paper sent me elsewhere.

KISS1 in melanoma research

In the 1996 KISS1 paper, the experiment involved human malignant melanoma cells and athymic nude mice. Introducing KISS1 into the metastatic cells suppressed metastasis while leaving their ability to form tumors intact. Metastasis is cancer's spread to other sites; that distinction between spread and tumor formation is central to the result.

The precision of that original finding appeals to me. It describes a change in a particular model, with an important activity left untouched. The name of the gene and the name of the peptide that later emerged from it can make the history seem smoother than it was. At the beginning, the question concerned cancer spread. The reproductive significance still lay ahead.

Two researchers examining a culture dish beside an inverted microscope
An imagined cell-culture research scene, illustrating the experimental setting rather than a particular laboratory or discovery.

The GPR54 families

The 2003 receptor study by Seminara and colleagues linked loss-of-function mutations in GPR54 to absent or incomplete puberty in humans, with low LH and FSH. Mice lacking the receptor reproduced the phenotype. In de Roux and colleagues' study, a family with five affected siblings carried a deletion in the same receptor gene.

Here the keystone comparison feels earned. Disrupt a particular component and an important transition fails. The receptor genetics commands my respect; the appealing name adds little. The receptor, now called KISS1R, also provided an experimental route into the mechanism: work in mice and sheep connected its activation to GnRH release and circulating LH. GnRH is gonadotropin-releasing hormone, a signal at the center of reproductive control.

Prolonged signaling and early puberty

The 2008 report of a girl with central precocious puberty added a striking counterpart. Her GPR54 mutation was associated with prolonged responsiveness to kisspeptin in laboratory testing. The finding linked enhanced receptor signaling to early pubertal activation. Its scope is a reported patient and an experiment on the receptor; it offers no simple account of every instance of early puberty.

Then an inactivating KISS1 mutation reported in 2012 connected failure of puberty to the peptide's own gene. My strongest impression from this sequence is how much the argument depends on the relationship between signal and receiver. A peptide concentration alone would tell a thinner story. That relationship becomes more awkward, and more interesting, when researchers try repeated stimulation.